Navigation Links
Premier Research Appoints Troy W. McCall, Ph.D. as Chief Executive Officer
Date:10/1/2009

PHILADELPHIA, Oct. 1 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical and medical device services company, announces the promotion of its current Chief Operating Officer, Troy W. McCall, Ph.D. to Chief Executive Officer. The appointment is part of the company's longstanding succession plan to support current CEO Dr. Simon Yaxley's desire to transition to an advisory role with the company's Board of Directors as Deputy Chairman.

Michael Barry, Non-Executive Chairman of the Board of Premier Research Group Limited, said, "On behalf of the Board, I would like to thank Dr. Yaxley for his efforts, commitment to excellence, and vision as CEO and Co-founder of Premier Research. Dr. McCall's commitment, drive, and deep understanding of the business make him the ideal successor to ensure that Premier Research maintains its outstanding track record of growth and customer service."

Dr. McCall's move into the CEO role is effective immediately and follows on the heels of nearly three years with the company as COO where he has led the successful integration of four acquisitions, established a global organization, and achieved year on year organic growth in excess of 20%. During Dr. McCall's tenure as COO, the company has initiated support of medical device trials in the U.S., launched a Functional Sourcing group, expanded the company's clinical research sites, and completed the company's first ever NDA submission on behalf a sponsor. Dr. McCall's leadership has firmly established Premier Research as a high quality, full-service, global CRO.

Dr. Simon Yaxley, Deputy Chairman, commented, "It is exciting and rewarding to have Troy stepping into the CEO role. This is what we have been working together towards and he deserves the recognition. I can think of no one more suited to continue to grow this successful company we, and many others, have worked hard to create. I also look forward to my continued involvement in the business as we continue to grow both organically as well as through acquisition."

Dr. McCall stated, "When I joined Premier Research, it was with the primary goal for the company to become the CRO of choice for global pharmaceutical and biotechnology companies. I am proud to say that we have completed several important milestones, and we are well on our way. This would not have been possible without the efforts and contributions of everyone in the organization. I am grateful for those efforts and look forward to continuing to exceed our client's expectations though our focus on operational excellence and unparalleled customer service."

About Premier Research

Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, neuroscience, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.

Premier Research has 30 offices and operates in more than 30 countries across North America and Europe employing more 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

www.premier-research.com

SOURCE Premier Research Group Limited


'/>"/>
SOURCE Premier Research Group Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Premier Heart Launches Multifunction CardioGram(TM) (MCG) In Latin America and the Caribbean
2. Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress
3. Premier Research Announces Milestone Investigational New Drug Application
4. Premier Research Expands its Medical Device Operations to the United States
5. Premier Research Announces Milestone New Drug Application
6. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
7. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
8. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
9. Premier Micronutrient Launches Supplement for Hearing Health
10. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
11. Ganeden Biotech Announces Grants for Early Investigators to Research Probiotic GanedenBC30
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... March 27, 2017  A recent study at Shriners ... freestanding hospitals in the country dedicated to the treatment ... surgery, concluded that the Surfacide Helios ® UV-C ... in reducing bacterial pathogens not killed by the EVS ... at the American Burn Association,s 49th Annual Meeting in ...
(Date:3/27/2017)... , March 27, 2017 ... 7,000 attendees and more than 600 exhibitors from ... discover opportunities and solutions that will advance the ... April 2017 at the Messe Stuttgart, ... preeminent medical technology platform showcasing the key trends ...
(Date:3/27/2017)... March 27, 2017  Sophiris Bio Inc. (NASDAQ: ... a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) ... today reported fourth quarter and full year 2016 ... Key Corporate Highlights: Advanced ... Cancer. During 2016, the Company reported successful results ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... , ... The Anaheim Hills office accelerates and supports FNCC’s growth and further ... sales professionals over the past 6 months and is continuing to recruit new talent ... course of 2017. , “This new office is a direct result of our ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... with opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in ... Bill (AB) 1512, which proposes a tax on prescription opioids to fund drug ...
(Date:3/25/2017)... ... ... Swissray is pleased to announce the release of the ELITE DXA, a new bone ... scan window, which is more than double that of existing bone densitometers. Historically, subjects ... an accurate total body bone density or body composition study. The ELITE DXA ...
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software innovation lab specializing in ... a Greenville, South Carolina location. The lab has set up shop at ... been working with South Carolina clients for years from our office here in Atlanta,” ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... related services to families and business owners across eastern Michigan, is connecting with ... families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ...
Breaking Medicine News(10 mins):